Environmental surveillance gains ground in animal health

Environmental surveillance is getting a fresh push in veterinary science, with a new Frontiers in Veterinary Science review arguing that testing environmental samples for pathogens should move from a niche tool toward a more formal role in animal health surveillance. The review examines evidence across 15 domestic animal diseases and frames environmental sampling as a complement, not a replacement, for conventional animal diagnostics in a One Health setting. (frontiersin.org)

That message lands at a time when animal health systems are under pressure to detect outbreaks earlier, cover more species and production settings, and work more closely with public health and environmental partners. WOAH’s surveillance guidance already emphasizes that surveillance design has to match the target population, epidemiology, timing, geography, and environmental conditions, while the broader One Health agenda has increasingly pushed veterinary, human, wildlife, and environmental sectors toward shared surveillance models. (woah.org)

In the review itself, the authors highlight how the best environmental matrix depends on the pathogen and setting. They point to surface water and wetland sediments for infectious avian influenza virus isolation, pooled environmental feces and slurry for Johne’s disease surveillance, and electrostatic dust cloths for detecting small-ruminant viral pathogens in market environments. Across methods, the paper says molecular tools, especially qRT-PCR and droplet digital PCR, tend to outperform conventional culture on sensitivity and speed. It also flags wastewater-based epidemiology as a growing veterinary application, citing examples such as piggery effluent surveillance for Japanese encephalitis virus and wastewater metagenomics for antimicrobial resistance. (frontiersin.org)

The paper’s more important contribution may be its caution. The authors note that environmental matrices can interfere with testing, that protocols remain inconsistent across studies, and that detecting pathogen nucleic acid is not the same as proving viable, infectious pathogen is present. That concern echoes broader surveillance literature, including recent reviews of wastewater surveillance that describe the field as promising but still limited by uneven sampling strategies, weak cross-sector data integration, and the absence of clear response triggers tied to surveillance findings. (frontiersin.org)

Outside the paper, the wider policy conversation appears to be moving in the same direction. A 2026 U.S. Government Accountability Office report said experts identified wastewater surveillance, risk-based animal surveillance, and more diverse collection and testing techniques as areas where emerging disease surveillance could be improved. WOAH has likewise continued to emphasize stronger coordination across veterinary, wildlife, and environmental sectors, including in its recent One Health materials and case studies. Taken together, that suggests the review is arriving into a receptive policy environment, even if practice on the ground remains uneven. (files.gao.gov)

Why it matters: For veterinarians, diagnosticians, and animal health officials, the practical value here is less about any single assay and more about surveillance architecture. Environmental sampling could expand coverage where direct animal sampling is logistically hard, increase herd- or flock-level sensitivity in some settings, and provide earlier warning at farms, markets, transport interfaces, or wastewater collection points. But veterinary teams will need to be disciplined about interpretation. WOAH’s standards are a useful reminder that surveillance data are only as actionable as the sampling design, representativeness, and follow-up plan behind them. In other words, environmental surveillance may be most useful when it is built into structured decision-making, not treated as a stand-alone signal. (frontiersin.org)

There’s also a laboratory and workflow implication. If molecular methods are becoming the preferred approach for environmental samples, veterinary labs may face growing demand for validated extraction methods, inhibition controls, quantitative thresholds, and assays that better distinguish viable from non-viable pathogen signals. That could create opportunities for reference labs and surveillance networks, but it also raises questions about cost, standardization, and how results are communicated to producers, regulators, and pet parents when the epidemiologic meaning is still uncertain. This last point is an inference based on the review’s identified gaps and existing surveillance standards. (frontiersin.org)

What to watch: The next phase will likely center on standard-setting and implementation, whether researchers can produce field-validated, pathogen-specific protocols and viability-linked assays, and whether veterinary authorities start formally incorporating environmental data into routine surveillance dashboards, outbreak investigations, and One Health reporting systems over the next few years. (frontiersin.org)